| Followers | 19 |
| Posts | 6606 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Thursday, January 09, 2025 5:22:35 PM
WQLF SAYS; One on and Three to go..
“ Whenever dividends on any shares of Series A Preferred Stock have not been declared and paid for the equivalent of 12 or more monthly dividend periods, whether or not for consecutive months, the authorized number of directors on the Company's Board of Directors shall, at the next annual meeting of shareholders or at a special meeting of shareholders, automatically be increased by two and holders of shares of Series A Preferred Stock, voting together as a single class, shall be entitled to vote for the election of a total of two additional members of the Board of Directors.”
https://finance.yahoo.com/news/cbdmd-announces-companys-ceo-joins-205200673.html
CBDMD Board Members
As of the latest updates, cbdMD, Inc. has the following board members:
T. Ronan Kennedy: CEO, CFO, and Director/Board Member since December 18, 2024. Kennedy has been instrumental in leading cbdMD’s turnaround strategy and improving the company’s operational fundamentals.
Scott Stephen: Chairman since April 18, 2019. Stephen has been a key figure in guiding the company’s strategic direction.
Bakari Sellers: Director/Board Member since February 28, 2017. Sellers has been contributing to the board’s oversight and strategic decision-making.
William Raines: Director/Board Member since April 18, 2019. Raines supports the board in its governance and strategic initiatives.
Sibyl Swift: Chief Technology/Science/Research & Development Officer since April 28, 2021. Swift is responsible for the company’s technological and scientific advancements.
“ Whenever dividends on any shares of Series A Preferred Stock have not been declared and paid for the equivalent of 12 or more monthly dividend periods, whether or not for consecutive months, the authorized number of directors on the Company's Board of Directors shall, at the next annual meeting of shareholders or at a special meeting of shareholders, automatically be increased by two and holders of shares of Series A Preferred Stock, voting together as a single class, shall be entitled to vote for the election of a total of two additional members of the Board of Directors.”
https://finance.yahoo.com/news/cbdmd-announces-companys-ceo-joins-205200673.html
CBDMD Board Members
As of the latest updates, cbdMD, Inc. has the following board members:
T. Ronan Kennedy: CEO, CFO, and Director/Board Member since December 18, 2024. Kennedy has been instrumental in leading cbdMD’s turnaround strategy and improving the company’s operational fundamentals.
Scott Stephen: Chairman since April 18, 2019. Stephen has been a key figure in guiding the company’s strategic direction.
Bakari Sellers: Director/Board Member since February 28, 2017. Sellers has been contributing to the board’s oversight and strategic decision-making.
William Raines: Director/Board Member since April 18, 2019. Raines supports the board in its governance and strategic initiatives.
Sibyl Swift: Chief Technology/Science/Research & Development Officer since April 28, 2021. Swift is responsible for the company’s technological and scientific advancements.
Bullish
Recent YCBD News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 09:16:17 PM
- cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum • PR Newswire (US) • 05/14/2026 08:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:06:10 PM
- cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results • PR Newswire (US) • 05/12/2026 07:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:16:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:16:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:15:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:14:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:15:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:05:49 PM
- cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare • PR Newswire (US) • 04/01/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2026 05:15:15 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/04/2026 10:24:35 PM
- cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 • PR Newswire (US) • 02/17/2026 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:16 PM
- cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results • PR Newswire (US) • 02/12/2026 10:31:00 PM
- cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum • PR Newswire (US) • 02/02/2026 02:00:00 PM
- cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways • PR Newswire (US) • 01/29/2026 05:53:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2026 02:14:20 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 01/20/2026 09:05:38 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/14/2026 09:18:55 PM
- cbdMD Announces Strategic Acquisition of Bluebird Botanicals • PR Newswire (US) • 01/14/2026 02:00:00 PM
